Zelluna shareholders to vote on BioInvent CEO Martin Welschof as board director

Reuters2026/08/17 05:46

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Zelluna called an extraordinary general meeting on Sept. 9, 2026 to vote on a board appointment.
Shareholders will decide on electing BioInvent CEO Martin Welschof as a new director.
The nomination committee recommended Welschof, citing his clinical-stage biotech leadership and capital-markets experience.
Long-serving director and co-founder Hans Ivar Robinson has resigned from the board with immediate effect.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zelluna ASA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608170145OMX_____CNEWS_EN_GNW1001257850_en) on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Zelluna shareholders to vote on BioInvent CEO Martin Welschof as board director

You may also like

Crypto prices